Product Information
CARBIDOPA-LEVODOPA 25-250 TAB is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1149 per EA under NDC 62756098501. Its NADAC has been published 191 times since Jun 29, 2022.
Strength
25; 250 mg/1; mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756098501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA078536On Market Since
8/12/2021
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has been published 191 times since Jun 29, 2022, and over the history we have for it it has declined 23.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1149 per EA |
|---|---|
| All-time high | $0.1512 (Oct 12, 2022) |
| All-time low | $0.0731 (Apr 17, 2024) |
| 52-week high | $0.1403 |
| 52-week low | $0.1149 |
| Median price | $0.1375 |
| Average price | $0.1317 |
| Largest weekly change | +71.8% (Jun 19, 2024) |
| Weeks tracked | 191 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVODOPA 25-250 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA 25-250 TAB, manufactured by Sun Pharmaceutical Industries Inc., is $0.1149 per EA (NDC 62756098501), effective Feb 18, 2026.
How has the price of CARBIDOPA-LEVODOPA 25-250 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has declined 23.1%. It has been tracked across 191 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA 25-250 TAB?
Since Jun 29, 2022, the NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has ranged from a low of $0.0731 (Apr 17, 2024) to a high of $0.1512 (Oct 12, 2022), with a median of $0.1375 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVODOPA 25-250 TAB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CARBIDOPA-LEVODOPA 25-250 TAB, but none are currently priced below it.
Who manufactures CARBIDOPA-LEVODOPA 25-250 TAB?
CARBIDOPA-LEVODOPA 25-250 TAB (NDC 62756098501) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification